Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism

Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism

US Patent 9481709 · Granted Nov 1, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfur-containing ionizable lipids for the delivery of nucleic acids and other t2024
Lipid-linked prodrugs2020
Amino lipids and methods for the delivery of nucleic acids2020
Thin reinforced product and tire comprising said product2019
Modified drugs for use in liposomal nanoparticles2018
Method for the synthesis of a hydrazine that can be used in the treatment of the2018
Amino lipids and methods for the delivery of nucleic acids2015
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors2015
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors2014
Modified drugs for use in liposomal nanoparticles2014
Lipids and compositions for the delivery of therapeutics2014
Modified drugs for use in liposomal nanoparticles2013